KETOSIS, KETOACIDOSIS AND THE FDA’S WARNING ON A CLASS OF DIABETES DRUGS
KETOSIS VS. KETOACIDOSIS: THEY’RE NOT AT ALL THE SAME: Why a new class of diabetes drug got an FDA warning The FDA recently issued a warning of a risk of ketoacidosis from a new class of type 2 diabetes drugs. The drugs, called Farxiga, Invokana, and Jardiance are SGLT2 inhibitors. They make it easier … Read more